Health Media ArticlesExcerpts of Key Health Media Articles in Major Media
Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
Johnson & Johnson and its cosmetics lobby have known about the link between its talcum powder and cancer for 40 years, distorted research about the talcum-cancer connection, and lied to the public about the dangers. The big lie was exposed [when] jurors blasted Johnson & Johnson with an 8-figure verdict in a trial charging that the company knew that its talc-based Baby Powder and Show to Shower Powder causes ovarian cancer. Talc was found in the ovarian tissue after a hysterectomy of the plaintiff, Gloria Ristesund. She was diagnosed with cancer in 2011 after using J&J’s talc-based feminine hygiene products for almost 40 years, and the jury awarded her $55 million. Another jury in the same courthouse awarded $72 million on February 22 to the family of Jacqueline Fox of Birmingham, AL, who used Johnson’s baby powder for 35 years. She was diagnosed with ovarian cancer in 2013 and died last year. For decades, according to the plaintiffs, J&J and its lobby the Talc Interested Party Task Force (TIPTF) distorted scientific papers to prevent talc from being classified as a carcinogen. As a result, J&J is facing now 1,200 lawsuits in Missouri and New Jersey, charging it with fraud, negligence, conspiracy, and failing to warn consumers about the cancer risks. Talc is a mineral [that] absorbs moisture well and helps reduce friction. The risk of ovarian cancer is one-third higher among women who regularly powdered their genitals with talc, according to a 2016 study in Epidemiology.
Note: J & J was eventually fined over $4 billion in this case. For more, see this article. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health.
Don’t want to get a vaccine for yourself or your child? Prepare to face the consequences. In the last month, a Detroit mother went to jail because she refused to vaccinate her child. Fifty people lost their jobs at a group of Midwestern hospitals and clinics because they declined a flu shot. And an Oregon university has blocked students from registering for classes unless they have a meningitis shot. All states have some vaccine requirements for public education—no shots, no school. All but three states - Mississippi, West Virginia and California - allow parents to send their child to school without vaccines based on some kind of non-medical exemption. In 2013, more than 90 percent of American children had been vaccinated for chicken pox, hepatitis B, measles, mumps and rubella, according to the Centers for Disease Control and Prevention. However, a significant number of people ... hesitate when a doctor offers them a vaccine. A new study released on Monday found that 27 percent of the parents surveyed could be classified as moderately or highly hesitant around vaccines. That same study found these people may be particularly concerned with the purity of vaccines. Increasingly, parents who choose not to vaccinate are warned of harsh penalties. People who choose not to vaccinate themselves may also face serious consequences. Some states have laws guiding which vaccinations people working at hospitals or other health care facilities must have; more often, requirements may be enshrined in a facility's policy, not in law.
Note: Watch an excellent video of Emmy award winning reporter Sharyl Attkisson exposing how the government fired an vaccine expert who found links to autism. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
When the drugs came, they hit all at once. It was the 80s, and by the time one in 10 people had slipped into the depths of heroin use - bankers, university students, carpenters, socialites, miners - Portugal was in a state of panic. In 2001 ... Portugal became the first country to decriminalise the possession and consumption of all illicit substances. Rather than being arrested, those caught with a personal supply might be given a warning, a small fine, or told to appear before a local commission – a doctor, a lawyer and a social worker – about treatment, harm reduction, and the support services that were available to them. The opioid crisis soon stabilised, and the ensuing years saw dramatic drops in problematic drug use, HIV and hepatitis infection rates, overdose deaths, drug-related crime and incarceration rates. HIV infection plummeted from an all-time high in 2000 of 104.2 new cases per million to 4.2 cases per million in 2015. Portugal’s remarkable recovery ... could not have happened without an enormous cultural shift, and a change in how the country viewed drugs. Portugal’s policy rests on three pillars: one, that there’s no such thing as a soft or hard drug, only healthy and unhealthy relationships with drugs; two, that an individual’s unhealthy relationship with drugs often conceals frayed relationships with loved ones, with the world around them, and with themselves; and three, that the eradication of all drugs is an impossible goal. In spite of Portugal’s tangible results, other countries have been reluctant to follow.
Non-stop activity isn’t the apotheosis of productivity. It is its adversary. Researchers are learning that it doesn’t just mean that the work we produce at the end of a 14-hour day is of worse quality than when we’re fresh. This pattern of working also undermines our creativity and our cognition. Over time, it can make us feel physically sick – and even, ironically, as if we have no purpose. “The idea that you can indefinitely stretch out your deep focus and productivity time to these arbitrary limits is really wrong,” says research scientist Andrew Smart. “If you’re constantly putting yourself into this cognitive debt, where your physiology is saying ‘I need a break’ but you keep pushing yourself, you get this low-level stress response that’s chronic – and, over time, extraordinarily dangerous.” One meta-analysis found that long working hours increased the risk of coronary heart disease by 40% – almost as much as smoking (50%). Another found that people who worked long hours had a significantly higher risk of stroke, while people who worked more than 11 hours a day were almost 2.5 times more likely to have a major depressive episode than those who worked seven to eight. The reason we have eight-hour work days at all was because companies found that cutting employees’ hours had the reverse effect they expected: it upped their productivity. If eight-hour days are better than 10-hour ones, could even shorter working hours be even better? Perhaps.
Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
The World Health Organization said on Monday it hoped to conduct a full review by the end of the year of a dengue vaccine that was suspended last week in the Philippines. On Friday, the department of health halted its dengue immunization program after the manufacturer, French drug company Sanofi Pasteur, announced the vaccine, [commonly known as Dengvaxia], must be strictly limited due to evidence it can worsen dengue in people not previously exposed to the infection. The government of Brazil, where dengue is common, confirmed it already had recommended restricted use of the vaccine. Amid mounting public concern, Sanofi explained its "new findings" at a news conference in Manila on Monday but did not say why action was not taken after a WHO report in mid-2016 that identified the risk the company was now flagging. Nearly 734,000 children ... in the Philippines have received one dose of the vaccine as part of a programme that cost 3.5 billion pesos (more than $80 million Cdn). The Philippines Department of Justice on Monday ordered the National Bureau of Investigation to look into "the alleged danger to public health ... and if evidence so warrants, to file appropriate charges." There was no indication that Philippines health officials knew of any risks. However, the WHO said in a July 2016 research paper that "vaccination may be ineffective or may theoretically even increase the future risk" of severe dengue illness in people who hadn't been exposed to it prior to their first vaccination.
Note: Read more about this and about the way vaccines dangers are being covered up on this webpage. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
The Philippines ordered an investigation on Monday into the immunization of more than 730,000 children with a vaccine for dengue that has been suspended following an announcement by French drug company Sanofi that it could worsen the disease in some cases. The World Health Organization said it hoped to conduct a full review by year-end of data on the vaccine, commercially known as Dengvaxia. In the meantime, the WHO recommended that it only be used in people who had a prior infection with dengue. The government of Brazil, where dengue is a significant health challenge, confirmed it already had recommended restricted use of the vaccine but had not suspended it entirely. Amid mounting public concern, Sanofi explained its "new findings" at a news conference in Manila but did not say why action was not taken after a WHO report in mid-2016 that identified the risk it was now flagging. A non-governmental organization (NGO) said it had received information that three children who were vaccinated with Dengvaxia in the Philippines had died and a senator said he was aware of two cases. Last week, the Philippines Department of Health halted the use of Dengvaxia after Sanofi said it must be strictly limited due to evidence it can worsen the disease in people not previously exposed to the infection. Nearly 734,000 children aged 9 and over in the Philippines have received one dose of the vaccine as part of a program that cost 3.5 billion pesos ($69.54 million).
Note: This US government webpage states, "Since 1988, over 18,897 petitions have been filed with the VICP [Vaccine Injury Compensation Program]. Over that 29-year time period, 16,857 petitions have been adjudicated, with 5,782 of those determined to be compensable. Total compensation paid over the life of the program is approximately $3.7 billion." Why aren't these large numbers being reported in the media? For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
Aluminium in vaccines may cause autism, controversial new research suggests. Autistic children have up to 10 times more of the metal in their brains than what is considered safe in adults, a study found. Study author Professor Chris Exley from Keele University, said: 'Perhaps we now have the link between vaccination and autism spectrum disorder (ASD), the link being the inclusion of an aluminium adjuvant in the vaccine.' The researchers speculate autism sufferers may have genetic changes that cause them to accumulate aluminium which healthy people are able to remove. Research at Keele University, published in the Journal of Trace Elements in Medicine and Biology, provides the strongest indication yet that aluminium is a cause of ASD. The aluminium content of brain tissues from five donors who died with a diagnosis of ASD was found to be extraordinarily high; some of the highest values yet measured in human brain tissue. Why for example, would one of the four major brain lobes of a 15-year-old boy with autism be 8.74 (11.59) micrograms/g dry weight - a value which is at least 10 times higher than might be considered as acceptable for an adult never mind a child? The new evidence strongly suggests aluminium is entering the brain in ASD via inflammatory cells which have become loaded up with aluminium in the blood and/or lymph, much as has been for certain immune cells at injection sites for vaccines that contain aluminium to increase the body's immune response.
Note: For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
Against the backdrop of the nation's largest Veterans Day parade, Democratic Gov. Andrew Cuomo announced this month he'd sign legislation making New York the latest in a fast-rising tide of states to OK therapeutic pot as a PTSD treatment, though it's illegal under federal law. Twenty-eight states plus the District of Columbia now include PTSD in their medical marijuana programs, a tally that has more than doubled in the last two years. The increase has come amid increasingly visible advocacy from veterans' groups. Retired Marine staff sergeant Mark DiPasquale says the drug freed him from the 17 opioids, anti-anxiety pills and other medications that were prescribed to him for migraines, post-traumatic stress and other injuries from service that included a hard helicopter landing in Iraq in 2005. In a sign of how much the issue has taken hold among veterans, the 2.2-million-member American Legion began pressing the federal government this summer to let Department of Veterans Affairs doctors recommend medical marijuana where it's legal. The Legion started advocating last year for easing federal constraints on medical pot research, a departure into drug policy for the nearly century-old organization. "People ask, `Aren't you the law-and-order group?' Why, yes, we are," Executive Director Verna Jones said at a Legion-arranged news conference early this month at the U.S. Capitol. But "when veterans come to us and say a particular treatment is working for them, we owe it to them to listen and to do scientific research required."
Note: This Associated Press article no longer appears on CNBC's website. Here's an alternate link for the complete article. The illegal drug MDMA was recently fast tracked for FDA approval after preliminary studies found it to be effective for treating PTSD in a therapeutic context. While police in the US arrest more people for marijuana use than for all violent crimes combined, articles like these suggest that the healing potentials of mind-altering drugs are gaining mainstream credibility.
The sugar industry funded animal research in the 1960s that looked into the effects of sugar consumption on cardiovascular health - and then buried the data when it suggested that sugar could be harmful, according to newly released historical documents. Stanton Glantz, a professor of medicine at U.C.S.F. and an author of the new report, said that even though the newly discovered documents are 50 years old, they are important because they point to a decades-long strategy to downplay the potential health effects of sugar consumption. “This is continuing to build the case that the sugar industry has a long history of manipulating science,” Dr. Glantz said. The documents described in the new report are part of a cache of internal sugar industry communications that Cristin E. Kearns, an assistant professor at the U.C.S.F. School of Dentistry, discovered in recent years. Last year, an article in The New York Times highlighted some of the previous documents that Dr. Kearns had uncovered, which showed that the sugar industry launched a campaign in the 1960s to counter “negative attitudes toward sugar” in part by funding sugar research that could produce favorable results. The campaign was orchestrated by John Hickson, a top executive at the sugar association who later joined the tobacco industry. Mr. Hickson secretly paid two influential Harvard scientists to publish a major review paper in 1967 that minimized the link between sugar and heart health and shifted blame to saturated fat.
Note: Read more about the sugar industry conspiracy. For more along these lines, see concise summaries of deeply revealing news articles on corruption in the food system and in the scientific community.
A Minnesota-based health system has fired about 50 employees who refused to get a flu shot. Essentia Health announced last month that employees would be required to get vaccinated for influenza unless they received a religious or medical exemption. The company said it wanted to help keep patients from getting sick at its 15 hospitals and 75 clinics in Minnesota, Idaho, North Dakota and Wisconsin. Essentia says 99 percent of the company's 13,900 eligible employees had gotten the shot, received an exemption or were getting an exemption by the Monday deadline. The United Steelworkers filed an injunction to try to delay the policy, but a federal judge denied the request. Minnesota Public Radio reports at least two other unions are filing grievances on behalf of workers who lost their jobs.
Note: For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
Regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken. The digital pill combines two existing products: the former blockbuster psychiatric medication Abilify - long used to treat schizophrenia and bipolar disorder - with a sensor tracking system first approved in 2012. Experts say the technology could be a useful tool, but it will also change how doctors relate to their patients as they’re able to see whether they are following instructions. The pill has not yet been shown to actually improve patients’ medication compliance, a feature insurers are likely to insist on before paying for the pill. Additionally, patients must be willing to allow their doctors and caregivers to access the digital information. The technology carries risks for patient privacy, too, if there are breaches of medical data or unauthorized use as a surveillance tool, said James Giordano, a professor of neurology at Georgetown University Medical Center. “Could this type of device be used for real-time surveillance? The answer is of course it could,” said Giordano. The new pill, Abilify MyCite, is embedded with a digital sensor that is activated by stomach fluids, sending a signal to a patch worn by the patient and notifying a digital smartphone app that the medication has been taken.
Note: In 2010, it was quietly reported that Novartis AG would be seeking regulatory approval for such "chip-in-a-pill technology". For more along these lines, see concise summaries of deeply revealing news articles on microchip implants and the disappearance of privacy.
Does energy healing work? Charlie Goldsmith knows it does. The Australian energy healer, who reluctantly discovered his talent at the ripe age of 18, is now on a mission to take energy medicine mainstream. To date, Goldsmith has volunteered his time - and talents - to two scientific studies. In the first study, published in The Journal of Alternative and Complementary Medicine in 2015, he treated 50 reports of pain at a 76% success rate and 29 reports of non-pain problems at a 79% success rate. The study, conducted at NYU's Lutheran Hospital ... landed him a TV deal. The second is still underway. Prior to the studies done in the public eye, Goldsmith spent years healing as many as he could, often those who had been failed by countless doctors and traditional medicine. He has never once charged for his work. Dr. Ramsey Joudeh, from NYU's Lutheran Medical Center, attests to Goldsmith's miraculous healing powers: "Most of our narcotics decrease a patient's pain by three to five points. If you go from a 10, meaning the worst pain you can imagine, to five, that's significant. In some cases Charlie reduced a patient's pain from 10 to zero. He also treated people with infections where antibiotics were not effective. You could see the shift in a patient's status from stagnant to a rapid healing resolution. I can't quantify it, but I would say Charlie cuts off patients' hospital stays. Watching him work has been humbling in the most extreme way."
Note: See this miracle worker's website at https://www.charliegoldsmith.com.
The nation’s leading heart experts on Monday issued new guidelines for high blood pressure that mean tens of millions more Americans will meet the criteria for the condition. Under the guidelines ... the number of men under age 45 with a diagnosis of high blood pressure will triple, and the prevalence among women under age 45 will double. The number of adults with high blood pressure, or hypertension, will rise to 103 million from 72 million under the previous standard. The number of people who are new candidates for drug treatment will rise ... by an estimated 4.2 million people. To reach the goals others may have to take more drugs or increase the dosages. The change is due largely to convincing data from a federal study published in 2015. That study, called Sprint, explored whether markedly lower blood pressure in older people - lower than researchers had ever tried to establish - might be both achievable and beneficial. In participants who were assigned to get their systolic pressures below 120, the incidence of heart attacks, heart failure and strokes fell by a third, and the risk of death fell by nearly a quarter. But more intensive drug treatment in so many more patients may increase rates of kidney disease. In the Sprint trial, the incidence of acute kidney injury was twice as high in the group receiving drugs to reduce their systolic pressure to 120. Lifestyle changes like diet and exercise can help many patients lower blood pressure. But many of the newly diagnosed are likely to wind up on drugs.
Note: The effect of this huge change is that billions more dollars will now flow into Big Pharma as millions of consumers are led to believe their blood pressure is dangerously high. Are drugs the best answer? For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption and health.
President Donald Trump on Monday announced he is nominating Alex Azar, a former pharmaceutical company executive and George W. Bush administration official, to succeed Tom Price as the secretary of the Department of Health and Human Services. He previously served as HHS general counsel and deputy secretary for President George W. Bush. Following his time with the administration, he worked for pharmaceutical giant Eli Lilly & Co. [He] became president of Lilly USA in 2012. As part of his role at Lilly USA, Azar was on the board of directors for the Boards of the Biotechnology Industry Organization (BIO), a drug lobbying group. In an October letter, Reps. Raul Grijalva, D-Arizona, Mark Pocan, D-Wisconsin, and Jan Schakowsky, D-Illinois, wrote that under his leadership, Azar's company fought "against federal and state legislation to increase drug pricing transparency." And a lawsuit filed in Massachusetts in early 2017 alleges that the company shot up prices on insulin "in near lock step" with two other pharmaceutical manufacturers. Following Yale Law School, Azar clerked for Supreme Court Justice Antonin Scalia, and later joined the Whitewater independent counsel headed by his "mentor" Ken Starr.
Note: Rather than draining the swamp, Trump continues to deepen the swamp in his administration. Besides this most recent appointment, he has installed Goldman Sachs executives as his Treasury secretary, top economic adviser, deputy national security adviser and chief strategist. Even his top Wall Street regulator is a former attorney for Goldman. For more, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry.
Opposition from France and Italy doomed a European Union vote on Thursday to reauthorize the world’s most popular weedkiller, glyphosate, a decision that came hours after Arkansas regulators moved to ban an alternative weedkiller for much of 2018. The decisions are a double blow to the agrochemical industry and particularly to the chemicals giant Monsanto. The effort to reauthorize the weedkiller failed to receive a majority even though regulators were seeking only a five-year reauthorization instead of the typical 15, amid controversy and disputes about cancer risk that have made glyphosate’s future in Europe uncertain. Its approval in the region expires in mid-December. In Arkansas, regulators voted on Wednesday to ban the use of another major weedkiller, dicamba ... amid widespread reports of crop damage. Dicamba has been around for decades, but new versions have been developed by Monsanto, BASF and DuPont as an alternative to Roundup. Taken together, the decisions reflect an increasing political resistance to pesticides in Europe and parts of the United States, as well as the specific shortcomings of dicamba. Dicamba has damaged more than 3.6 million acres of soybean crops in 25 states. The European Union’s decision followed years of haggling and delay. But glyphosate ... has been plunged into controversy since the International Agency for Research on Cancer, part of the World Health Organization, declared it a probable carcinogen in 2015.
Note: Monsanto was recently banned from the European parliament after shunning important hearings with regulators. This company's use of scientists as industry puppets, its lies to regulators and the public and its massive lobbying campaign have not kept information on the risks and dangers of its products from getting out. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.
More than 6,000 cases of mumps were reported in the United States last year, the highest number in 10 years. Around 2010, total annual cases were down in the hundreds. Most of the recent cases occurred in outbreaks, including a large one in Arkansas, rather than as a sporadic here-a-case, there-a-case disease. Most of the outbreaks were among people 18 to 22 years old, most of whom had had the requisite two doses of mumps vaccine in childhood. “We are seeing it in a young and highly vaccinated population,” Dr. Routh said. Mumps is transmitted by droplets of saliva or mucus. It can be spread by coughing and sneezing, but also by sharing cups ... close contact. Many of the recent outbreaks occurred in college dorms or among athletic teams. Mumps vaccine is now combined with measles and rubella vaccine in the M.M.R., given at ages 1 and 4. But the immunity wanes over time in some people, and with close contact, there can be sufficient exposure to sufficient quantities of virus to overcome the vaccines’ protection. Dr. Alan Lucerna [also] reported in February 2017 on a case of mumps in a fully immunized adult, in an article titled “Still a pain in the neck after all this time.”
Intermittent fasting can keep the body ‘young’ at a cellular level. Researchers at Harvard found that temporarily restricting diet keeps the mitochondria – an important part of the cell to health aging – in homeostasis, which in turn helps to improve lifespan. Last year, Newcastle University research confirmed the crucial role of the mitochondria in human cell aging, and therefore, the aging of our bodies. Mitochondria break down carbohydrates and fatty acids, giving energy to the cell. For this reason, they are often referred to as the ‘powerhouses’ of our cells. The Newcastle University researchers found that without their aged mitochondria, cells appeared younger. Mitochondria exist in two states, and when they are alternating appropriately between these two states, they are in homeostasis. The Harvard researchers found that mitochondria stay in homeostasis better when an organism – in their study, a nematode worm – has an intermittently restricted diet. At the same time, being able to swing as they’re supposed to from one state to the other is key to the longevity-enhancing effects of intermittent fasting. The researchers also found that intermittent fasting helped to coordinate the activities of the mitochondria with peroxisomes, other cell parts that have an antioxidant effect and contribute to longevity. This newfound understanding of how fasting works at a cellular level could be a key to discovering therapies that could be beneficial to extending life expectancies and keeping the body younger.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
In July, the Food and Drug Administration took the important step of approving two final-phase clinical trials to determine whether a party drug that has long been on the Drug Enforcement Administration’s Schedule I list of banned substances could be used to treat a psychiatric condition that afflicts millions. The drug is MDMA, a psychedelic commonly known as Ecstasy. The trials aim to determine whether the drug is, as earlier trials have suggested, a safe and effective treatment for post-traumatic stress disorder. The F.D.A. approval is a beacon of hope for the roughly eight million Americans believed to suffer from PTSD, a group that includes victims of abuse, refugees and combat veterans. The shortcomings in the way we have typically treated PTSD mean that many are condemned to suffer from the condition for years, even decades, with little relief. Less than 20 percent of patients are estimated to get effective treatment through prescription psychiatric drugs ... which, along with psychotherapy, have been the global standard of mental health care since the 1990s. This could change with the F.D.A.’s decision, which has given MDMA-assisted psychotherapy for the treatment of PTSD the status of a potential “breakthrough therapy.” This designation permits the fast-tracking of trials in hopes of proving the drug, which has psychedelic and stimulant effects, to be safe and capable of doing what no other drug on the market can.
Note: Read more about how MDMA has been found to be highly effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.
The latest study to look at the long-term effects of Roundup, a popular weed killer developed by Monsanto in the 1970s, raises questions about the herbicide’s possible contributions to poor health. The study ... tracked people over the age of 50 in southern California from 1993-1996 to 2014-2016, with researchers periodically collecting urine samples. The percentage of people who tested positive for a chemical called glyphosate, which is the active ingredient in the herbicide Roundup, shot up by 500% in that time period. The levels of glyphosate also spiked by 1208% during that time. Exactly what that means for human health isn’t quite clear yet. One trial from the UK, in which rats were fed low levels of glyphosate throughout their lives, found that the chemical contributed to ... a condition in which fat accumulates in the liver and contributes to inflammation and scarring of the tissue. [Researcher Paul] Mills says that the levels of glyphosate documented in the people in his study were 100-fold greater than those in the rats. Mills says the findings should make people more aware of what they are ingesting along with their food. While Roundup was developed to eliminate most weeds from genetically modified crops - and thus reduce the amount of pesticides sprayed on them - recent studies have found that many weeds are now resistant to Roundup. That means growers are using more Roundup, which could only exacerbate potential negative health effects on people who consume those products.
Note: Glyphosate is the most heavily used agricultural chemical in human history. According to a recent UN report, "the assertion promoted by the agrochemical industry that pesticides are necessary to achieve food security is not only inaccurate, but dangerously misleading." For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.
Federal agents arrested the founder of a major drug company in an early-morning raid Thursday on charges stemming from an alleged scheme to get doctors to illegally prescribe a powerful opioid to patients who don't need it. John Kapoor ... is the billionaire founder and former CEO of the pharmaceutical company Insys Therapeutics. He faces charges including racketeering, conspiracy, bribery and fraud. Kapoor is the most significant pharmaceutical executive to be criminally charged in response to the nationwide opioid crisis. Kapoor stepped down as CEO of Insys in January but still serves on its board. The company makes a spray version of fentanyl, a highly addictive opioid intended only for cancer patients. Authorities allege Insys marketed the drug as part of a scheme to get non-cancer doctors to prescribe it. Numerous physicians were allegedly paid bribes by the company to push the painkilling drug. Insys made 18,000 payments to doctors in 2016 that totaled more than $2 million. Headache doctors, back pain specialists and even a psychiatrist ... received thousands of dollars to promote the drug last year. Last December, six other Insys executives were indicted on federal charges in Boston in connection with the alleged scheme to bribe doctors to unnecessarily prescribe the painkilling drug.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.